Medicine and Dentistry
Prostate Cancer
67%
Clustered Regularly Interspaced Short Palindromic Repeat
59%
Cells
57%
DNA Repair
50%
Combination Therapy
49%
Radiation Response
44%
Cell Line
41%
Relative Biologic Effectiveness
39%
X-Ray
39%
Radiosensitivity
39%
Irradiation
35%
Cancer Cell
33%
Linear Energy Transfer
33%
Unfolded Protein Response
29%
Programmed Cell Death
21%
DNA Damage
19%
Survival
17%
Cell Survival
17%
Cell DNA
15%
Cell Type
14%
Non-Homologous End Joining
13%
Biological Activity
13%
Mechanism of Action
13%
Therapeutic Procedure
13%
Sensitization
11%
Cell Cycle
10%
DNA Repair
9%
Ploidy
9%
Castration Resistant Prostate Cancer
9%
Overall Survival
9%
Radium
9%
Patient
8%
Tissues
8%
Analysis
8%
Double Stranded DNA
7%
Clonogenic Assay
7%
Radiation Therapy
6%
Gene
6%
Dosimetry
6%
Radioisotope
6%
Cancer Therapy
6%
Dasatinib
6%
Cancer Mortality
5%
Malignant Neoplasm
5%
Oxidative Phosphorylation
5%
RNA Sequencing
5%
Man
5%
Short Course Therapy
5%
Biochemistry, Genetics and Molecular Biology
Alpha Radiation
63%
CRISPR
59%
Radiation
52%
X Ray
43%
Dose
42%
DNA Repair
41%
Relative Biologic Effectiveness
39%
Radiosensitivity
39%
Linear Energy Transfer
29%
Mitotic Catastrophe
29%
Dasatinib
29%
DNA Damage
16%
Survival
15%
Epirubicin
14%
Claudin
14%
Transcription Factor Slug
14%
Transcription Factor Snail
14%
Cell Survival
14%
Kinetics
14%
Non-Homologous End Joining
13%
Ploidy
11%
Sensitization
11%
Proton
9%
Gene Mutation
8%
DNA
8%
Clonogenic Assay
7%
Photon
6%
Nested Gene
6%
Human Cell
5%
CRISPR/Cas9
5%
Cell Cycle
5%
Development
5%
Metabolic Pathway
5%
Association
5%
Biological Activity
5%
Cell Death
5%
Bone
5%
Overall Survival
5%
Solution and Solubility
5%
Volume
5%
Pharmacology, Toxicology and Pharmaceutical Science
DNA
100%
Prostate Cancer
59%
Survival
43%
Irradiation
37%
Protein
35%
Ionizing Radiation
29%
Proton
29%
Breast Cancer
29%
Lutetium 177
29%
Castration Resistant Prostate Cancer
29%
Ataxia Telangiectasia
23%
Cell Death
21%
Double Stranded DNA
19%
Olaparib
17%
Radiopharmaceutical Agent
14%
Malignant Neoplasm
13%
Cell Cycle
11%
Radium
9%
Castration Resistant Prostate Cancer
9%
Overall Survival
9%
Chemical Bond
9%
Sensitization
7%
Carbon
7%
Erethism
7%
X-Ray
7%
Diseases
7%
Dasatinib
6%
Drug
5%
Clinical Trial
5%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
5%
Dose Fractionation
5%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
5%
Radiosensitizing Agent
5%
Cancer Mortality
5%
Human
5%
Neoplasm
5%
Microscopy
5%
Phosphotransferase
5%
Flow Cytometry
5%
RNA
5%